These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9357307)
1. Cumulative viral titer reduction demonstrated by sequential challenge of a tangential flow membrane filtration system and a direct flow pleated filter cartridge. Aranha-Creado H; Fennington GJ PDA J Pharm Sci Technol; 1997; 51(5):208-12. PubMed ID: 9357307 [TBL] [Abstract][Full Text] [Related]
2. Virus retention by a hydrophilic triple-layer PVDF microporous membrane filter. Aranha-Creado H; Oshima K; Jafari S; Howard G; Brandwein H PDA J Pharm Sci Technol; 1997; 51(3):119-24. PubMed ID: 9203825 [TBL] [Abstract][Full Text] [Related]
3. Membrane filtration for virus removal. Brandwein H; Aranha-Creado H Dev Biol (Basel); 2000; 102():157-63. PubMed ID: 10794103 [TBL] [Abstract][Full Text] [Related]
4. Clearance of murine leukaemia virus from monoclonal antibody solution by a hydrophilic PVDF microporous membrane filter. Aranha-Creado H; Peterson J; Huang PY Biologicals; 1998 Jun; 26(2):167-72. PubMed ID: 9811524 [TBL] [Abstract][Full Text] [Related]
5. Evaluation and validation of virus removal by ultrafiltration during the production of diaspirin crosslinked haemoglobin (DCLHb). Azari M; Boose JA; Burhop KE; Camacho T; Catarello J; Darling A; Ebeling AA; Estep TN; Pearson L; Guzder S; Herren J; Ogle K; Paine J; Rohn K; Sarajari R; Sun CS; Zhang L Biologicals; 2000 Jun; 28(2):81-94. PubMed ID: 10885615 [TBL] [Abstract][Full Text] [Related]
6. Performance of a novel Viresolve NFR virus filter. Brough H; Antoniou C; Carter J; Jakubik J; Xu Y; Lutz H Biotechnol Prog; 2002; 18(4):782-95. PubMed ID: 12153313 [TBL] [Abstract][Full Text] [Related]
7. The use of a microporous polyvinylidene fluoride (PVDF) membrane filter to separate contaminating viral particles from biologically important proteins. Oshima KH; Evans-Strickfaden TT; Highsmith AK; Ades EW Biologicals; 1996 Jun; 24(2):137-45. PubMed ID: 8889061 [TBL] [Abstract][Full Text] [Related]
8. Improvement of virus safety of an antihemophilc factor IX by virus filtration process. Kim IS; Choi YW; Kang Y; Sung HM; Sohn KW; Kim YS J Microbiol Biotechnol; 2008 Jul; 18(7):1317-25. PubMed ID: 18667862 [TBL] [Abstract][Full Text] [Related]
9. Inactivation and clearance of viruses during the manufacture of high purity factor IX. Johnston A; Macgregor A; Borovec S; Hattarki M; Stuckly K; Anderson D; Goss NH; Oates A; Uren E Biologicals; 2000 Sep; 28(3):129-36. PubMed ID: 10964439 [TBL] [Abstract][Full Text] [Related]
10. Phage passage after extended processing in small-virus-retentive filters. Lute S; Bailey M; Combs J; Sukumar M; Brorson K Biotechnol Appl Biochem; 2007 Jul; 47(Pt 3):141-51. PubMed ID: 17286554 [TBL] [Abstract][Full Text] [Related]
11. Comparison of filtration properties of hepatitis B virus, hepatitis C virus and simian virus 40 using a polyvinylidene fluoride membrane filter. Oshima KH; Evans-Strickfaden T; Highsmith A Vox Sang; 1998; 75(3):181-8. PubMed ID: 9852404 [TBL] [Abstract][Full Text] [Related]
12. Achieving a Successful Scale-Down Model and Optimized Economics through Parvovirus Filter Validation using Purified TrueSpikeTM Viruses. De Vilmorin P; Slocum A; Jaber T; Schaefer O; Ruppach H; Genest P PDA J Pharm Sci Technol; 2015; 69(3):440-9. PubMed ID: 26048749 [TBL] [Abstract][Full Text] [Related]
13. Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus. Roush DJ; Myrold A; Burnham MS; And JV; Hughes JV Biotechnol Prog; 2015; 31(1):135-44. PubMed ID: 25395156 [TBL] [Abstract][Full Text] [Related]
14. RUNspike, a complementary virus filter spiking method: a solution to the problem of reduced throughput due to the addition of the virus spike. Parrella J; Wu Y; Kahn DW; Genest P PDA J Pharm Sci Technol; 2009; 63(6):547-58. PubMed ID: 20169861 [TBL] [Abstract][Full Text] [Related]
15. Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification. Wickramasinghe SR; Kalbfuss B; Zimmermann A; Thom V; Reichl U Biotechnol Bioeng; 2005 Oct; 92(2):199-208. PubMed ID: 16041807 [TBL] [Abstract][Full Text] [Related]
16. Internal virus polarization model for virus retention by the Ultipor(®) VF Grade DV20 membrane. Jackson NB; Bakhshayeshi M; Zydney AL; Mehta A; van Reis R; Kuriyel R Biotechnol Prog; 2014; 30(4):856-63. PubMed ID: 24616397 [TBL] [Abstract][Full Text] [Related]
17. Filter preconditioning enables representative scaled-down modelling of filter capacity and viral clearance by mitigating the impact of virus spike impurities. Khan NZ; Parrella JJ; Genest PW; Colman MS Biotechnol Appl Biochem; 2009 Apr; 52(Pt 4):293-301. PubMed ID: 18844606 [TBL] [Abstract][Full Text] [Related]
18. Efficient removal of viruses by a novel polyvinylidene fluoride membrane filter. Roberts P J Virol Methods; 1997 Apr; 65(1):27-31. PubMed ID: 9128859 [TBL] [Abstract][Full Text] [Related]
19. Development and qualification of a novel virus removal filter for cell culture applications. Liu S; Carroll M; Iverson R; Valera C; Vennari J; Turco K; Piper R; Kiss R; Lutz H Biotechnol Prog; 2000; 16(3):425-34. PubMed ID: 10835245 [TBL] [Abstract][Full Text] [Related]
20. Virus removal from factor IX by filtration: validation of the integrity test and effect of manufacturing process conditions. Roberts PL; Feldman P; Crombie D; Walker C; Lowery K Biologicals; 2010 Mar; 38(2):303-10. PubMed ID: 20089418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]